Evaluating Suprathel 250 Membrane for Healing Oropharyngeal Wounds After Tonsillectomy

What this Trial Is About

Researchers are evaluating the use of Suprathel 250, a synthetic biodegradable membrane, for healing wounds in the oropharyngeal area after tonsillectomy procedures. The study compares the application of Suprathel 250 on the wound bed to leaving the wound bare to heal naturally. This investigation aims to see if Suprathel 250 can reduce postoperative pain and improve the quality of life for patients recovering from tonsillectomy. Participants are randomly assigned to one of two groups one where the wound bed is left bare after surgery, and another where the Suprathel 250 membrane is sutured onto the wound bed using resorbable interrupted sutures. The study follows a parallel design with single masking, focusing on treatment effects. The membranes impact on mucosal reconstruction and healing is assessed over the postoperative period. During the study, participants will be monitored for pain intensity using a visual analog scale VAS on postoperative days 0, 1, 2, 3, 4, 5, 7, and 10. Secondary outcomes related to healing and recovery are evaluated up to 10 days after surgery. The study involves informed consent and aims to observe healing progress and patient comfort, with an expected study completion date in April 2027.

SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds